Principal Financial Group Inc. Has $311.99 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Principal Financial Group Inc. lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 550,872 shares of the medical equipment provider's stock after selling 7,279 shares during the period. Principal Financial Group Inc. owned about 0.15% of Intuitive Surgical worth $311,992,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Newbridge Financial Services Group Inc. increased its position in Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 33 shares in the last quarter. Holos Integrated Wealth LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $25,000. Olistico Wealth LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $28,000. Laurel Wealth Advisors LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $31,000. Finally, Turning Point Benefit Group Inc. increased its position in Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider's stock worth $32,000 after purchasing an additional 50 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Down 0.2%

ISRG opened at $451.38 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $427.84 and a twelve month high of $603.88. The company has a fifty day moving average of $473.81 and a 200-day moving average of $517.22. The stock has a market cap of $159.86 billion, a PE ratio of 54.71, a price-to-earnings-growth ratio of 3.61 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to analysts' expectations of $2.62 billion. During the same period in the prior year, the company posted $1.81 earnings per share. Intuitive Surgical's revenue for the quarter was up 23.0% compared to the same quarter last year. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent research reports. Robert W. Baird upped their target price on Intuitive Surgical from $575.00 to $610.00 and gave the stock an "outperform" rating in a report on Wednesday, April 22nd. Citigroup raised Intuitive Surgical from a "neutral" rating to a "buy" rating and set a $590.00 target price for the company in a report on Wednesday, March 11th. Barclays set a $651.00 target price on Intuitive Surgical and gave the stock an "overweight" rating in a report on Thursday, April 23rd. JPMorgan Chase & Co. lowered their target price on Intuitive Surgical from $625.00 to $550.00 and set an "overweight" rating for the company in a report on Wednesday, April 22nd. Finally, UBS Group lowered their target price on Intuitive Surgical from $570.00 to $550.00 and set a "neutral" rating for the company in a report on Tuesday, March 17th. Eighteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $581.91.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 119 shares of the firm's stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director owned 120 shares of the company's stock, valued at $55,620. This trade represents a 49.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Myriam Curet sold 105 shares of the firm's stock in a transaction that occurred on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 5,906 shares of company stock valued at $2,907,726 over the last 90 days. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.